O xidation products of linoleic acid and other free fatty acids (FFAs) affect several different cell types in a profound manner (Table 1) . [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] Oxidized FFA (Ox-FFA) also abounds in oxidized LDLs (Ox-LDLs) and in atherosclerotic lesions. 16, 17 Several cell types generate Ox-FFA via several reactions. For example, the secretion of lipoxygenase products by endothelial cells, smooth muscle cells, and macrophages has been well documented and such reactions are activated during the atherosclerotic process. 18 -22 In our extensive review of literature, we noted that there is a void of information on the uptake of Ox-FFA by these various cell types. In other words, despite their importance as cellsignaling molecules, little is known regarding their uptake and metabolism by cells. To understand how Ox-FFAs affect cells, it is essential to document the extent of their uptake and metabolism.
FFA is readily transported across cell membranes and is predominantly metabolized by esterification reactions to form complex lipid. 23 The uptake and fate of Ox-FFA, in contrast, have received little attention. A few short-term studies have looked at the incorporation of oxidized arachidonic acid derivatives (mostly lipoxygenase products) into endothelial cell lipids and have shown that hydroxyeicosatetraenoic acids (HETEs) are incorporated into both neutral lipids and phospholipids. 18 Differences in incorporation among various oxidized products of arachidonic acids were also observed, suggesting that different Ox-FFAs might suffer from different intracellular fate. 24 The incorporation of hydroxyeicosatetraenoic acids (HETEs) into cholesteryl esters by the acylcoenzyme A (acyl-CoA) cholesterol:acyltransferase (ACAT) reaction was much lower compared with those of unoxidized fatty acids. 25, 26 Studies on the incorporation of ricinoleic acid (12-hydroxyoleic acid) in castor phospholipids using microsome fractions also showed that the utilization of Ox-FFA was poor compared with that of oleic acid. 27 Haas et al 24 showed that there was specific binding of H-hydroxyeicosatetraenoic acid ([ 3 H]HETE), but no binding of 13-hydroxyoctadecadienoic acid (13-HODE) in human umbilical vein endothelial cells.
In this study we have determined the uptake of 13-hydroperoxyoctadecadienoic acid (13-HPODE), using 1-14 Clabeled 13-HPODE by macrophages, smooth muscle cells, and endothelial cells. 1-14 C-labeled oleic (as oxidation-resistant FFA) and linoleic (as oxidation-susceptible FFA) acids were used as controls. Our results indicate clearly that cells take up 13-HPODE poorly and that the levels of uptake depend on the cell type.
To our knowledge, the utilization of 13-HPODE for acylation reactions has not been demonstrated. We observed that 13-HPODE is poorly used by microsomal enzymes as a substrate for the formation of phosphatidylcholine (PtdCho) from lysophosphatidylcholine (lysoPtdCho).
Based on these results, we propose that the biological effects of 13-HPODE could be because of its interaction with specific components of cell-surface membrane.
Methods

Materials
RPMI medium (RPMI 1640), MEM and DMEM, penicillin, streptomycin, glutamine, trypsin, and Hanks' balanced salt solution (HBSS) were purchased from Mediatech Inc. Linoleic and oleic acid, soybean lipoxygenase, lysoPtdCho, anti-guinea pig IgG conjugated with horseradish peroxidase, epidermal growth factor, hydrocortisone acetate, dibutyryl cAMP were obtained from Sigma Chemicals. [1- 14 C]Linoleic (53 mCi/mmol) and oleic acid (58 mCi/mmol) were obtained from New England Nuclear. Other reagents and solvents were obtained from Fisher Chemicals. Guinea pig CD36 polyclonal antibody was a generous gift from Drs Mysore Ramprasad and Daniel Steinberg (University of California San Diego).
Cell Culture
Rabbit femoral artery smooth muscle cells (RFASMCs) were obtained from the American Type Culture Collection (ATCC, Rockville, Md) and were routinely grown in MEM medium, 10% FCS containing 1% L-glutamine, 1% penicillin, and 1% streptomycin. Human umbilical vein endothelial cells (HUVECs, Clonetics Corp) were grown in M199 medium, 10% FCS containing 1% L-glutamine, 1% penicillin, and 1% streptomycin. RAW macrophage cells (RAW 264.7 from ATCC) were cultured in DMEM medium, 10% FCS, 1% L-glutamine, 1% penicillin, and 1% streptomycin. Human microvascular endothelial cells (MVECs) were obtained from the Dermatology core cell service facility, Emory University, and were grown routinely in endothelial basal media (Clonetics Corp) with epidermal growth factor 5 ng/mL, hydrocortisone acetate 1 mol/L, 30% human serum, 5ϫ10
Ϫ5 dibutyryl cAMP, 1% L-glutamine, 1% penicillin, and 1% streptomycin. MVECs express CD36 after 4 days when cultured in the absence of growth factor and in the presence of cAMP. 28 Swiss-Webster mice (22 to 25 g) were purchased from Harlan (Birmingham, Ala) and euthanized after anesthesia (ether) by CO 2 asphyxiation. Mouse peritoneal macrophages (MPMs) were recovered by peritoneal lavage with 5 mL of cold RPMI 1640 medium and isolated by centrifugation. The cells were seeded in 12-well culture plates and cultured in RPMI 1640 medium, 1% L-glutamine, 1% penicillin, and 1% streptomycin. The medium was replaced each day for 3 days to remove nonadherent cells.
Isolation of LDL and the Preparation of Acetyl-LDL
Blood was collected from healthy donors, and LDL (dϭ1.019 to 1.063) was isolated by ultracentrifugation as previously described, 29 using a TL-100 tabletop ultracentrifuge. The isolated LDL was dialyzed against PBS, pH 7.4, for 6 hours. Ac-LDL was prepared as described by Pitas et al. 30 
Preparation of Labeled Solution of Fatty Acids
The stock solution of radioactive linoleic or oleic acid (5000 dpm/nmol) was prepared in absolute ethanol and diluted in HBSS. The linoleic acid solution was oxidized with immobilized soybean lipoxygenase (100 U/mL, 1 hour, 37°C) to prepare 13-HPODE. The formation of 13-HPODE was monitored spectrophotometrically by scanning the absorption between 200 and 300 nm (Model DB-3500; SLM-Aminco), using HBSS as reference. Under these conditions, the conversion into 13-HPODE is observed as an increase in absorbance at the optical density of 234 nm. Usually, Ͼ90% conversion of linoleic acid to 13-HPODE was achieved. Identity of the 13-HPODE was confirmed by using HPLC.
Uptake of Unoxidized and Oxidized Fatty Acids by Cells
Cells were seeded at a final density of 2ϫ10 5 cells per well in routine culture medium in 6-well plates (RFASMCs or HUVECs) or 12-well plates (RAW or peritoneal macrophages) for 16 hours. The medium was then removed, the cells were washed twice with HBSS, and the experiments were performed in the absence of serum by using 50 mol/L (5000 dpm/nmol) of labeled solution of FFA. As soon as the labeled FFA was added to the medium, an aliquot was mixed with EcoLume (ICN) for the determination of radioactivity. After 30 minutes of incubation, the medium was collected and the cells were washed twice with HBSS containing 0.5% BSA. A serum-free medium was used to prevent excess lipids. As the duration of the experiment was very short, lack of serum did not result in cytotoxicity or cell death. Radioactivity in an aliquot of the mixture (culture medium and cell washings) was determined to establish the remaining labeled FFA in the medium. The cells were solubilized in 1.9 mL of deoxycholic acid solution (0.5 mg/mL) and the radioactivity was determined in 100 L of the cell extract. After acidification by adding 20 L of 6 N HCl, 4 mL of chloroform/methanol (1:1, vol/vol) was added to the 1.8 mL of cell lysate to extract the cellular lipids. 31 All extraction procedures had 10 mmol/L of butylated hydroxytoluene included to prevent further oxidation. After centrifugation (10 minutes, 3000 rpm), 500 L of the upper phase was gently dried (37°C, under nitrogen) and the radioactivity was determined. The lower chloroform phase was collected and 100 L was gently dried (37°C, under nitrogen) and the radioactivity of FFA associated with cellular lipids was determined. The remaining chloroform phase was gently dried (37°C, under nitrogen) and saved for the identification of cellular lipids by thin layer chromatography (TLC).
Incorporation of [1-14 C]FFA Into Cellular Lipids
The dried chloroform phase was dissolved in 100 L of chloroform/ methanol (2:1, vol/vol) and the neutral lipids were separated by TLC on silica gel G60 analytical plates, using a solvent system containing n-hexane/diethyl ether/acetic acid (90:18:1.5, by volume). The neutral lipids and the phospholipids were identified by using iodine in the presence of standards. The lipid spots at the origin, corresponding to the phospholipids, were scraped off, suspended in 500 L of water, and extracted according to the method of Folch et al. 32 After gently drying the chloroform phase (37°C, under nitrogen), the phospholipids were separated by using TLC silica gel G60 analytical plates and a solvent system of chloroform/methanol/water/acetic acid (65:25:3:1, by volume). The phospholipids were identified by exposure to iodine in the presence of standards. Spots were scraped off and the radioactivity was determined.
Isolation of Microsomes From Rat Liver and RAW Macrophages
Microsomes were isolated from rat liver and RAW cells by differential centrifugation as previously described. 33 Microsomal fractions 
Biological Effects of Oxidized Fatty Acids
Microsomal Acyltransferase Activity
Microsomal acyltransferase activity was performed in a final volume of 800 L of Tris-HCl (0.1 mol/L, pH 7.4) as described by Parthasarathy et al. 35 In brief, 100 g of rat liver or RAW macrophage microsomal protein was incubated in the presence of 50 mol/L [1-14 C]oleic acid or [1-14 C]linoleic acid (500 dpm/nmol) or 13-HPODE (500 dpm/nmol) as a substrate, 100 mol/L lysoPtdCho (acyl receptor), 200 mol/L ATP, 200 mol/L magnesium chloride, and 1 mol/L of CoA for 1 hour at 37°C. After this incubation, lipids were extracted and the phospholipids were separated by TLC as described earlier.
Cell Cholesterol Esterification Assay
MPMs were seeded at the final density of 2ϫ10 5 cells per well in RPMI 1640 medium containing 10% FCS, 1% glutamine, penicillin, and streptomycin for 48 hours in 12-well culture plates. The medium was removed, and the cells were washed twice with HBSS and incubated for 16 hours in complete media without serum. The experiments were performed in RPMI 1640, 1% glutamine, penicillin, streptomycin in the presence of 25 g/mL of acetyl-LDL (Ac-LDL) and 50 mol/L of labeled solution of FFA (5000 dpm/nmol). As soon as the labeled FFA was added to the medium, the radioactivity in the culture media was determined. After 30 minutes or 6 hours of incubation, the medium was collected and the cells were washed twice with HBSS. The lipids were extracted and separated by TLC, using a neutral lipid solvent system as described earlier. The 1-14 C-cholesteryl ester was identified by using iodine in the presence of standards. The corresponding spot were scraped off and the radioactivity was determined.
CD36 Expression
Cells (2ϫ10 6 per dish) were solubilized in a lysis buffer by sonication and centrifuged (12 500g, 10 minutes, 4°C). CD36 was identified in the proteins from the supernatant (100 g) by using western blot (SDS-PAGE 10%). In brief, after electrotransfer, the nitrocellulose membrane was incubated for 2 hours in the blocking buffer of 20 mmol/L Tris-buffered saline (TBS) pH 7.4 and 0.1% Tween 20 containing 10% nonfat milk at room temperature and then 2 hours in the blocking buffer containing 1% nonfat milk and anti-CD36 antibody (1:150 dilution). After extensive washing, the secondary antibody was added to the membrane (anti-guinea pig IgG conjugated with horseradish peroxidase; dilution, 1:1500) for 1 hour at room temperature. The protein was identified by chemiluminescence, using the ECL detection kit available from Amersham.
Results
Uptake of FFA by Different Cell Types
Cells (HUVECs, MVECs, RFASMCs, RAW, and MPMs) were incubated with [1- 14 C]oleic acid, [1-14 C]linoleic acid, or HPODE at a final concentration of 50 mol/L at 37°C for 30 minutes, and cell-associated radioactivity was determined. Because some of the cell types used in the study (RAW and MPMs) may convert linoleic acid into oxidized products during incubation, 36 we used oleic acid (an oxidation resistant fatty acid) as a control. To our knowledge, this is the first study that compares the uptake of oxidation-resistant, oxidation-susceptible, and an Ox-FFA by different cell types.
After 30 minutes of incubation, 14.5% to 50% of unoxidized FFA (oleic and linoleic acids) were associated with cells ( Figure 1 ). Of the cell types studied, RFASMCs showed the least uptake of fatty acids ( Figure 1A, 14 .5% or 42Ϯ4-nmol/mg of protein). In HUVECs and MVECs Ϸ30% (81Ϯ6.5 nmol/mg of protein) of the 1-14 C-unoxidized fatty acid added to the media were found associated with cellular lipids ( Figure 1B and 1C) . The percentage of lipid-associated radioactivity was highest with macrophages (Ϸ40% or 86Ϯ7.2 nmol/mg of protein) ( Figure 1D and 1E). The incorporation of lipids was comparable between macrophages and endothelial cells. Although the uptake of oleic and linoleic acids was comparable in smooth muscle cells and endothelial cells, the uptake of linoleic acid was disproportionately high in macrophages. This could reflect the ability of these cells to accumulate large quantities of lipids or their ability to convert linoleic acid into 13-HPODE. 36 However, we do not have an explanation as to the difference noted in the uptake of linoleic acid compared with that of oleic acid. In contrast to unoxidized FFA, the uptake of 13-HPODE was significantly low (3% to 12%) by all cell types ( Figure  1 ). The uptake of HPODE was higher in macrophage cell lines (Ϸ10%, 13Ϯ1.8 nmol/mg of protein) compared with endothelial or smooth muscle cells (Ϸ2.5%, 5Ϯ1.2 nmol/mg of protein for smooth muscle cells and 3Ϯ0.5 nmol/mg of protein for endothelial cells). In these experiments, we had directly added the labeled HPODE from lipoxygenase incubations. As there was a possibility that these preparations contained some FFA, we also tested the uptake of TLCpurified 13-HPODE and observed similar results (data not shown).
We considered the possibility that the low uptake of 13-HPODE by cells could be because of insufficient time of incubation or limiting concentration of HPODE used in these incubations. However, the uptake of 13-HPODE by smooth muscle cells reached maximum levels at concentrations Ͻ20 mol/L ( Figure 2B ) whereas there was a concentrationdependent increase in the uptake of linoleic acid even up to 100 mol/L levels (Figure 2A) . Furthermore, although the 5 cells per well, as described in Methods. As soon as the labeled FFA (shaded columns, oleic acid; open columns, linoleic acid; or solid columns, 13-HPODE) were added in the medium (in the absence of serum), an aliquot was taken for determining the radioactivity. After 30 minutes of incubation, the medium-and the cell-(Uptake) associated radioactivity were quantified. Lipids were extracted and the radioactivity was evaluated in the methanol phase and in the chloroform phase (Lipids). Each experiment was performed at least 4 times, each time in duplicate. uptake of 13-HPODE increased during longer incubations, its levels never reached those of unoxidized FFA ( Figure 2C ). These results suggest that there is an intrinsic difference in the mechanism(s) by which FFA and Ox-FFA are taken up by cells.
Competition for the Uptake of 13-HPODE
Cells may take up 13-HPODE by passive diffusion through the membrane or via a regulated mechanism. To determine the potential involvement of a receptor-mediated mechanism in the uptake of 13-HPODE, we evaluated the ability of unlabeled 13-HPODE or oleic acid to compete with the uptake of a tracer amount of [1- 14 C]13-HPODE. A 9-fold excess of oleic acid did not inhibit the uptake of 5 mol/L [1-
14 C]13-HPODE. In contrast, the addition of a 9-fold excess of 13-HPODE resulted in an inhibition of 80% of the uptake. It is interesting that the addition of linoleic acid also generates substantial inhibition, suggesting perhaps the formation of unlabeled 13-HPODE and release into the medium in these incubations, as observed by others. 36 -38 The results indicate that only 13-HPODE competes with its own uptake in smooth muscle cells (Figure 3) . Similar results were obtained by using RAW cells (data not shown). This result may be interpreted to suggest an uptake of 13-HPODE different from that involved with FFA.
Incorporation of [1-14 C]FFA Into Cellular Lipids
Most of the radioactivity associated with cells in these incubations could be accounted for by FFA and phospholipid fractions ( Figure 4A and 4B, respectively) in all cell types. The major phospholipid that was labeled was PtdCho ( Figure  4C ). There was much lower radioactivity associated with the other phospholipid fractions (sphingomyelin, 17Ϯ2%; lysoPtdCho, 3Ϯ0.7%; and phosphatidylethanolamine, 6Ϯ1%), expressed as percentages of radioactivity incorporated into the phospholipid fraction (data not shown) with all fatty acids used. When the cells were incubated with 13-HPODE, most of the radioactivity incorporated into cellular lipids was associated with the phospholipid fraction, compared with cells incubated with unoxidized fatty acids. The results presented in Figure 4B were expressed as percentages of radioactivity incorporated into the cells and suggested that 13-HPODE is a better substrate for phospholipid acyltransferase reaction than unoxidized FFA. However, it should be remembered that the Ox-FFA taken up by cells is very low in comparison with unoxidized FFA. For this reason we determined the efficiency of the acyltransferase reaction by using rat liver or RAW microsome as the source of the enzyme and labeled oxidized and unoxidized FFA as substrate.
Oleic and Linoleic Acid Are Better Substrates for Microsomal Acyltransferase Reaction Than 13-HPODE
Both de novo synthesized fatty acids and exogenous fatty acids must be activated to acyl-CoA derivatives before they can enter a metabolic reaction. The formation of fatty acyl-CoA derivatives is catalyzed by the microsomal enzyme acyl-CoA synthetase. The product, acyl-CoA is also efficiently used for complex lipid synthesis by microsomal 14 C]13-HPODE, (5000 dpm/nmol) alone (none) or mixed with 45 mol/L of oleic or linoleic acid or 13-HPODE (HPODE), using the experimental conditions described in Figure 1 . After 30 minutes of incubation, lipids were extracted and the radioactivity was determined. This experiment was performed at least 3 times, in duplicate. acyltransferases. Dominant acyltransferases that determine the fate of fatty acid are the lysoPtdCho acyltransferase, the diacylglycerol acyltransferase, and the acyl-CoA-cholesterol acyltransferase, which generate phosphatidylcholine, triacylglycerol, and cholesteryl esters, respectively.
We measured the formation of PtdCho by using lysoPtdCho as acyl acceptor in the presence of RAW cell microsome ( Figure 5A ) or rat liver microsomes ( Figure 5B ). As seen in Figure 5 , oleic and linoleic acids were efficiently incorporated into phosphatidylcholine. In contrast 13-HPODE was poorly used by the enzyme to generate PtdCho. The enzyme was pretreated with cold 13-HPODE and purified by acetone precipitation. This pretreated enzyme was catalytically active and could incorporate 13-HPODE (data not shown). Increasing the concentration of 13-HPODE or the concentration of CoA had no effect on the rate of formation of phosphatidylcholine (data not shown). This suggested that the poor incorporation of 13-HPODE was not because of an inhibition of the enzyme or because of depletion in CoA by 13-HPODE. The decreased formation was also not because of differences in the mobility of PtdCho and oxidized PtdCho on the TLC system. In the solvent system used chloroform/methanol/ water/acid acetic (65:25:3:1, by volume), both phospholipids comigrate as a single spot.
Cholesterol Esterification in MPMs
Foam cells of atherosclerotic lesions accumulate large amounts of Ox-FFA, predominantly in the esterified form. 39 Endocytosis of modified lipoprotein is suggested to involve hydrolysis of the lipoprotein-derived cholesterol esters in the lysosomes and the reesterification of free cholesterol with the liberated fatty acids in the endoplasmic reticulum to generate cytoplasmic cholesteryl esters. 40, 41 AcLDL delivers lipoprotein cholesterol to macrophages by scavenger pathways and stimulates cholesterol esterification in MPMs. 42 Linoleic acid is the predominant unsaturated fatty acid associated with LDL and considerable 13-HPODE is formed during the oxidation of LDL. 43 If the cholesteryl ester associated with Ox-LDL were to undergo hydrolysis and the reesterification reaction, the released 13-HPODE would be expected to be incorporated readily into the cholesterol ester. The increased incorporation of exogenously added [1- 14 C]oleic acid into cellular cholesteryl esters under these conditions has been well documented. 44, 45 To our knowledge, the uptake and incorporation of 13-HPODE during the uptake of modified lipoproteins by macrophages have not been reported before. Because of our finding that 13-HPODE was taken up and incorporated poorly into cellular PtdCho by macrophages, we determined the uptake of 13-HPODE in the presence and absence of Ac-LDL by macrophages.
After incubation of cells with 25 g/mL of Ac-LDL and [1-
14 C]FFA or [1-14 C]13-HPODE for 30 minutes and 6 hours, we counted the radioactivity associated with cholesteryl esters. As the level of uptake of each fatty acid differs in MPMs, we expressed the results as percentages of the total radioactivity incorporated in cells. At 30 minutes of incubation there was very little incorporation of fatty acids. After 6 hours in the presence of Ac-LDL, cholesteryl esterification was greater when cells were incubated in presence of oleic or linoleic acid than in incubations performed in the presence of Ac-LDL and 13-HPODE ( Figure 6A and 6B).
CD36 Expression
CD36 has been suggested to be a receptor for Ox-LDL. However, recent evidence seems to suggest that CD36 might recognize the lipid components of Ox-LDL. 46 -48 In fact, studies by Endemann et al 48 showed that moderately Ox-LDL (which presumably would have more undegraded peroxides compared with that of fully oxidized LDL) was more readily recognized by CD36. Besides, a protein that bears substantial sequence homology to CD36 has been detected as a fatty acid transport protein in fibroblasts and adipocytes. 49, 50 In these studies, the possibility that CD36 or its homolog could bind to Ox-FFA has been suggested. As our finding suggested a difference in the levels of uptake of 13-HPODE among different cell types studied, we considered the possibility that the uptake could be linked to the differences in the expression of CD36. The results, as demonstrated by western blot analysis, indicate that RAW cells that take up Ox-FFA more than smooth muscle cells or endothelial cells express the 88-kDa CD36 at increased levels, whereas the other cell types only express the 54-kDa form of the protein ( Figure 7) . It is noteworthy that we observed only a poor expression of the 88-kDa CD36 protein in MPMs, which in contrast internalized much more 13-HPODE compared with smooth muscle cells or endothelial cells. We obtained similar results when anti-mouse CD36 antibody was used in western blotting (data not shown). Yet another evidence against the role of CD36 came from uptake experiments performed in the presence of MVECs that express CD36. 28 We observed no difference in the level of uptake of the 13-HPODE by these cells in comparison with HUVECs (2.4%) ( Figure 1C ), again suggesting that CD36 may not be involved in the uptake mechanism. However, we have not determined the expression of CD36 in these cells.
Discussion
There is growing interest in Ox-FFA metabolism because of their ability to induce in different cell types potent biological effects and signal transduction effects ( Table 1 ). The uptake of oxidized fatty acid by cells is poorly documented and most of the studies were performed by using 3 H derivatives of arachidonic acid, using predominantly endothelial cells as the model system. The results of these studies may not be a true representation of the uptake and metabolism of Ox-FFA, as 3 H radioactivity is readily displaced from fatty acids on oxidation. Furthermore, the fate of oxidized linoleic acid that is abundant in oxidized lipoproteins and contains only 2 double bonds would be quite different from that of arachidonic acid products. 26, 51 The results presented in this study show that (1) in contrast to FFAs, Ox-FFAs are poorly taken up by cells; (2) the level of uptake of Ox-FFAs by cells depends on the specific cell type; (3) uptake of Ox-FFA may not involve cellular expression of CD36; (4) Ox-FFAs are poorly used by microsomal acyltransferase; and (5) the mechanism of uptake of 13-HPODE is distinct from that of the uptake of FFA. More important, the results presented might suggest that the oxidized lipids that accumulate in the cholesteryl ester-rich macrophage foam cells could also originate from de novo intracellular oxidation of fatty acid components as suggested by Carpenter et al, 52 as very little HPODE was incorporated in cholesterol ester during the uptake of Ac-LDL. These studies could also be interpreted to suggest that 13-HPODE is not a good substrate for acyl-CoA cholesterol:acyltransferase (ACAT) reaction. However, atherosclerosis is a slow process and externally added 13-HPODE may not mimic the fate of lipoprotein-associated 13-HPODE.
The results presented in Figure 1 suggest that very low levels of Ox-FFAs themselves may be sufficient to induce cellular effects, or the effect of Ox-FFAs on cells could be attributed to extracellular events involving membrane modification. This latter possibility is very likely, as comparable levels of uptake were noticed in 2 types of endothelial cells (HUVECs and MVECs). The MVECs, in contrast to HUVECs, do not show an induction of VCAM after exposure to Ox-FFAs, 53 suggesting that the level of uptake of FFAs does not correspond to the cellular effect.
Specific receptors have been proposed for the plethora of cellular effects attributed to oxidized arachidonic acid products (the prostanoids). 54 Whether HPODE could interact with any of the putative oxidized arachidonic acid receptors or other components are involved remains to be established. Results presented in the current study suggest that CD36 may not be involved in the uptake of 13-HPODE. However, whether 13-HPODE binds to CD36 could not be determined.
The cellular effects of 13-HPODE are often counteracted by added antioxidants, suggesting the involvement of additional oxidation steps. 7 From the results presented in this study, it could be speculated that oxidation of specific plasma membrane targets facing the extracellular milieu by 13-HPODE could be a key event in eliciting cellular response. Whether the target is a lipid, a specific amino acid(s) component of proteins, or other components, including microdomains such as caveolae, remains to be established. Alternatively, the 13-HPODE that enters the cells could further propagate oxidation reactions (which could explain the presence of oxidized esterified lipids) or undergo catabolic reactions generating toxic products such as H 2 O 2 55 or short-chain dicarboxylic acids. 51 Figure 7 . Level of expression of CD36 in different cell types. Cells (smooth muscle cells, SMC; endothelial cells, EC; mouse peritoneal macrophages, MPM; or RAW macrophages, RAW) were lysed as described in Methods. After protein separation by 10% SDS-PAGE (100 g/sample), CD36 was identified by using western blotting.
